Skip to main content
. Author manuscript; available in PMC: 2014 Nov 1.
Published in final edited form as: Magn Reson Imaging. 2013 Aug 15;31(9):10.1016/j.mri.2013.07.002. doi: 10.1016/j.mri.2013.07.002

Table 4.

Analysis of imaging parameter changes (from pretreatment to after cycle 1) for discriminating pCR.

Imaging
parameter
% change for patients
with a pCR
% change for patients
without a pCR
p-value for
discriminating
patients with
a pCR
Median Range Median Range
Lesion size (mm)
 LAD (early) −17 −53 to +6 −4 −34 to +18 .08
 SAD (early) −11 −61 to +33 −12 −23 to +24 .70
 LAD (late) −15 −39 to +10 0 −30 to +18 .11
 SAD (late) −12 −52 to +22 −8 −23 to +26 .25
Enhancement 0 −38 to 0 0 −17 to +17 .49
Kinetics
 50% threshold
  % progressive
  (Type I)
+ 49 + 11 to +99 + 28 −39 to+335 .75
  % plateau
  (Type II)
−2 −39 to +36 −13 −51 to +47 .81
  % washout
  (Type III)
−54 −84 to −12 −8 −86 to +50 .11
 100% threshold
  % progressive
  (Type I)
+ 62 +26to + 134 +16 −40 to +336 .35
  % plateau
  (Type II)
−12 −56 to +26 −19 −86 to +61 .92
    % washout
    (Type III)
−62 −90 to −26 −7 −97 to + 58 .04

Bold = statistically significant at p < .05. pCR = pathological complete response, LAD = long-axis diameter, SAD = short-axis diameter, − = percentage decrease, + = percentage increase.